Youngjoo Lee

Genetic Alterations of K-ras, p53, c-erbB-2, and DPC4 in Pancreatic Ductal Adenocarcinoma and Their Correlation With Patient Survival

Sang Hyun Shin, Song Cheol Kim, Seung‐Mo Hong et al. · Pancreas · 2013 · 102 citations

Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

Youngjoo Lee, Sun Hye Kim, Ji‐Youn Han et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 91 citations · Full text

Advanced Lung Disease, Medicine, Standard Chemotherapy +9

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Byoung Chul Cho, Ji‐Youn Han, Sang‐We Kim et al. · Journal of Thoracic Oncology · 2021 · 88 citations · Full text

Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations

Youngjoo Lee · Cancer · 2014 · 63 citations · Full text

High <i>EGFR</i> Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma

Youngjoo Lee, Hyo Sup Shim, Moo Suk Park et al. · Clinical Cancer Research · 2012 · 63 citations